Sleeve gastrectomy: A new surgical approach for morbid obesity

Expert Review of Gastroenterology and Hepatology

Volumn 4, Issue 1, 2010, Pages 101-119

  Abu Jaish, Wasef ^a   Rosenthal, Raul J ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Bariatric surgery; Laparoscopy; Morbid obesity; Roux en Y gastric bypass; Sleeve gastrectomy

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOTIN; CITRATE CALCIUM; CYANOCOBALAMIN; GHRELIN; IRON; MULTIVITAMIN; RETINOL; VITAMIN B COMPLEX; VITAMIN D; VITAMIN K GROUP; ZINC;

ABDOMINAL WALL HERNIA; ANOREXIA; BARIATRIC SURGERY; BARRETT ESOPHAGUS; BODY MASS; COMMON BILE DUCT STONE; DIET SUPPLEMENTATION; DISEASE SEVERITY; GASTRECTOMY; GASTRIC ABSCESS; GASTRIC LEAK; GASTRIC STRICTURE; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE PRESSURE; LAPAROTOMY; LIFESTYLE; LUNG EMBOLISM; MINIMALLY INVASIVE SURGERY; MORBID OBESITY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; PYLORUS; QUALITY OF LIFE; REOPERATION; REVIEW; ROUX EN Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; SPLEEN INJURY; STOMACH EMPTYING; STOMACH HEMORRHAGE; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; WEIGHT REDUCTION; WOUND INFECTION;

BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; GASTRECTOMY; GASTRIC BYPASS; GASTROESOPHAGEAL REFLUX; HUMANS; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 77951681016     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.09.68     Document Type: Review

References (98)

1. US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. US Department of Health and Human Services, MD, USA (2001)
2. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical guidelines on the identifcation, evaluation and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health, MD, USA, 98-4083 (1998).
3. Buchwald H; Consensus Conference Panel. Consensus Conference Statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg. Obes. Relat. Dis. 1, 371-381 (2005).
4. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes. Surg. 15, 462-473 (2005).
5. Mason EE, Ito C. Gastric bypass in obesity. Surg. Clin. North Am. 47, 1345-1351 (1967).
6. Schauer PR, Ikramuddin S, Gourash W et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann. Surg. 232(4), 515-529 (2000).
7. Hickey MS, Pories WJ, MacDonald KG Jr et al A New Paradigm for Type 2 Diabetes Mellitus: Could It Be A Disease of the Foregut? Ann. Surg. 227, 637-643; Discussion 643-644 (1998).
8. Cottam DR, Mattar SG, Schauer PR. Laparoscopic era of operations for morbid obesity. Arch. Surg. 138, 367-375 (2003).
9. Rosenthal RJ, Szomstein S, Kennedy CI et al. Laparoscopic surgery for morbid obesity: 1,001 consecutive bariatric operations performed at the Bariatric Institute Cleveland Clinic Florida. Obes. Surg. 16, 119-124 (2006)
10. Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference Draft Statement. Obes. Surg. 1, 257-265 (1991).
11. Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes. Surg. 15, 692-699 (2005)
12. Proceedings of the ASBS Consensus Conference on the State of Bariatric Surgery and Morbid Obesity: health
13. implications for patients, health professionals and third-party payers, Washington, DC, USA, May 6-7, 2004. Surg. Obes. Relat. Dis. 1, 105-153 (2005).
14. Marceau P, Hould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J. Surg. 22, 947-954 (1998).
15. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes. Surg. 10, 514-523; discussion 524 (2000).
16. de Csepel J, Burpee S, Jossart G et al. Laparoscopic biliopancreatic diversion with a duodenal switch for morbid obesity: a feasibility study in pigs. J. Laparoendosc. Adv. Surg. Tech. A 11, 79-83 (2001).
17. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes. Surg. 8(3), 267-282 (1998).
18. Cottam D, Qureshi FG, Mattar SG et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg. Endosc. 20, 859-863 (2006).
19. Regan JP, Inabnet WB, Gagner M et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes. Surg. 13, 861-864 (2003).
20. Silecchia G, Boru C, Pecchia A et al. Effectiveness of laparoscopic sleeve gastrectomy (frst stage of biliopancreatic diversion with duodenal switch) on comorbidities in super-obese high-risk patients. Obes. Surg. 16, 1138-1144 (2006).
21. Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes. Surg. 15, 1030-1033 (2005).
22. Roa PE, Kaidar-Person O, Pinto D et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes. Surg. 16, 1323-1326 (2006).
23. Baltasar A, Serra C, Perez N et al. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes. Surg. 15, 1124-1128 (2005).
24. Sue-Ling DJAH. Surgical Management of Morbid Obesity, 3rd edition. Butterworth-Heinemann, Oxford, UK (1995).
25. Yehoshua RT, Eidelman LA, Stein M et al. Laparoscopic sleeve gastrectomy-volume and pressure assessment. Obes. Surg. 18(9), 1083-1088 (2008).
26. Marceau P, Cabanac M, Frankham PC et al. Accelerated satiation after duodenal switch. Surg. Obes. Relat. Dis. 1, 408-412 (2005).
27. Lin E, Gletsu N, Fugate K et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch. Surg. 139, 780-784 (2004).
28. Langer FB, Reza Hoda MA, Bohdjalian A et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes. Surg. 15(7), 1024-1029 (2005).
29. Broglio F, Koetsveld PV, Benso A et al. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J. Clin. Endocrinol. Metab. 87, 4829-4832 (2002).
30. Norrelund H, Hansen TK, Orskov H et al. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin. Endocrinol. 57, 539-546 (2002).
31. Frezza EE, Wachtel MS, Chiriva-Internati M. The multiple faces of glucagon-like peptide 1-obesity, appetite, and stress: what is next? A Review. DDS 52(3), 643-649 (2007).
32. Frezza, EE Are We Closer in Fnding the Treatment for Type II Diabetes Mellitus in Morbid Obesity-are the Incretins the Key to Success? Obes. Surg. 14(7), 999-1005 (2004).
33. Meier JJ, Gallwitz B, Schmidt WE, Nauck MA. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur. J. Pharmacol. 440, 269-279 (2002).
34. Christou NV, Look D, McLean AP. Pre and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass. Obes. Surg. 15(7), 1017-1023 (2005).
35. Ikezaki A, Hosoda H, Ito K et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 51(12), 3408-3411 (2002).
36. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with Type 2 diabetes following bariatric surgery. Diabetes 52, 1098-1103 (2003).
37. Lin E, Gletsu N, Fugate K et al. Insulin-associated downregulation of ghrelin expression in the morbidly obese and Type-2 diabetes (DM). J. Am. Coll. Surg. 197(Suppl. 3), S9 (2003).
38. Karamanakos SN, Vagenas K, Kalfarentzos F et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann. Surg. 247(3), 401-407 (2008).
39. Peterli R, Wölnerhanssen B, Peters T et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann. Surg. 250(2), 234-241 (2009).
40. Tucker O, Szomstein S, Rosenthal R. Indications for sleeve gastrectomy as a primary procedure for weight loss in the morbidly obese. J. Gastrointest. Surg. 12, 662-667 (2008).
41. Frezza EE. Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice? Surg. Today 37, 275-281 (2007).
42. Livingston EH, Huerta S, Arthur D et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann. Surg. 236, 576-582 (2002).
43. Dallal RM, Mattar SG, Lord JL et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes. Surg. 14(1), 47-53 (2004)
44. National Institutes of Health. Gastrointestinal surgery for severe obesity. NIH Consens. Statement 9(1), 1-20 (1991).
45. Nguyen NT, Longoria M, Gelfand DV et al. Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes. Surg. 15, 1077-1081 (2005).
46. Catheline JM, Cohen R, Khochtali I et al [Treatment of Super Super Morbid Obesity by Sleeve Gastrectomy]. Presse Med. 35, 383-387 (2006).
47. Langer F, Bohdjalian A, Felberbauer F et al Does Gastric Dilatation Limit the Success of Sleeve Gastrectomy As A Sole Operation for Morbid Obesity? Obes. Surg. 16, 166-171 (2006).
48. Moon Han S, Kim W W, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes. Surg. 15, 1469-1475 (2005).
49. Langer FB, Reza Hoda MA, Bohdjalian A et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes. Surg. 15, 1024-1029 (2005).
50. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a frst stage procedure for super-obese patients (BMI ≥ 50). Obes. Surg. 15, 612-617 (2005).
51. Lee CM, Feng JJ, Cirangle PT, Jossart GH. Laparoscopic vertical sleeve gastrectomy for morbid obesity in 216 patients: report of two-year results. SAGES 2006 Final Program 2006. Surg. Endosc. 21(10), 1810-1816 (2007).
52. Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy (LSG): review of a new bariatric procedure and initial results. Surg. Technol. Int. 15, 47-52 (2006).
53. Abu-Jaish W, Ramirez A, Patel S et al. Prevalence of nutritional defciencies after laparoscopic sleeve gastrectomy as a fnal step in morbidly obese patients. Presented at: The ASMBS 26th Annual Meeting. Grapevine, TX, USA, 21-26 June, 2009.
54. Cohen R, Uzzan B, Bihan H et al. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes. Surg. 15, 1024-1029 (2005).
55. Serra C, Baltasar A, Andreo L et al. Treatment of gastric leaks with coated self-expanding stents after sleeve gastrectomy. Obes. Surg. 17, 866-872 (2007).
56. Serra C, Baltasar A, Pérez N et al. Total gastrectomy for complications of the duodenal switch, with reversal. Obes. Surg. 16, 1082-1086 (2006).
57. Brethauer SA, Hammel J, Schauer PR. Systematic review of sleeve gastrectomy as a staging and primary bariatric operation. Surg. Obes. Relat. Dis. 5, 469-475 (2009).
58. Stroh C, Birk D, Flade-Kuthe R et al. Results of sleeve gastrectomy-data from a nationwide survey on bariatric surgery in Germany. Obes. Surg. 19, 105-112 (2009).
59. Gumbs A, Gagner M, Dakin G et al. Sleeve gastrectomy for morbid obesity. Obes. Surg. 17, 962-969 (2007).
60. Lalor PF, Tucker ON, Szomstein S et al. Complications after laparoscopic sleeve gastrectomy. Surg. Obes. Relat. Dis. 4(1), 33-38 (2008).
61. Frezza EE, Reddy S, Gee LL, Mitchtel S. Wachtel complications after sleeve gastrectomy for morbid obesity. Obes. Surg. 19, 684-687 (2009).
62. Arias P. Martinez P. Ka Ming Li V. Szomstein S. Rosenthal R. Mid-term follow-up after sleeve gastrectomy as a fnal approach for morbid obesity. Obes. Surg. 19(5), 544-548 (2009).
63. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes. Surg. 16, 1450-1456 (2006).
64. Hammoui N, Anthone GJ, Kaufman HS et al. Sleeve gastrectomy in the high-risk patient. Obes. Surg. 16, 1445-1449 (2006).
65. Kotidis E V, Koliakos GG, Baltzopoulos VG et al. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study. Obes. Surg. 16, 1425-1432 (2006).
66. Vidal J, Ibarzabal A, Romero F et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes. Surg. 18, 1077-1082 (2008).
67. Gagner M, Deitel M, Kalberer TL, Erickson AL,. Crosby RD. The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009. Surg. Obes. Relat. Dis. 5, 476-485 (2009).
68. Parikh M, Young L, Strain G et al. Laparoscopic sleeve gastrectomy: does bougie size affect mean %EWL? Short-term outcomes. Surg. Obes. Relat. Dis. 3, 353-357 (2007) (Abstract).
69. Kasalicky M, Michalsky D, Housova J et al. Laparoscopic sleeve gastrectomy without an over-sewing of the staple line. Obes. Surg. 18, 1257-1262 (2008).
70. Weiner RA, Weiner S, Pomhoff I et al. Laparoscopic sleeve gastrectomy-infuence of sleeve size and resected gastric volume. Obes. Surg. 17, 1297-1305 (2007).
71. Dapri G, Vaz C, Cadiere G et al. A prospective randomized study comparing two different techniques for laparoscopic sleeve gastrectomy. Obes. Surg. 17(11), 1435-1441 (2007).
72. Johnston D, Dachtler J, Sue-Ling HM et al. The Magenstrasse and Mill operation for morbid obesity. Obes. Surg. 13, 10-16 (2003).
73. Kotidis E, Koliakos G, Baltzopoulos V et al. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study. Obes. Surg. 16(11), 1425-1432 (2006).
74. Gumbs A, Gagner M, Dakin G et al. Sleeve gastrectomy for morbid obesity. Obes. Surg. 17, 962-969 (2007).
75. Klaus A, Weiss H Is Preoperative Manometry in Restrictive Bariatric Procedures Necessary? Obes. Surg. 18(8), 1039-1042 (2008).
76. Melissas J, Koukouraki S, Askoxylakis J et al Sleeve Gastrectomy: A Restrictive Procedure? Obes. Surg. 17, 57-152 (2007).
77. Braghetto I, Korn O, Valladares H et al. Laparoscopic sleeve gastrectomy: surgical technique, indications and clinical results. Obes. Surg. 17, 1442-1450 (2007).
78. Gan SS, Talbot ML, Jorgensen JO. Effcac of surgery in the management of obesity-related Type 2 diabetes mellitus. ANZ J. Surg. 7 7, 958-962 (2007).
79. Bergmann JF, Chassany O, Petit A et al. Correlation between echographic gastric emptying and appetite: infuence of psyllium. Gut 33(8), 1042-1043 (1992).
80. Akkary E, Duffy A, Bell R. Deciphering the sleeve: technique,indications, effcacy, and safety of sleeve gastrectomy. Obes. Surg. 18, 1323-1329 (2008).
81. Felberbauer FX, Langer F, Shakeri-Manesch S et al. Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from large series in three Austrian centers. Obes. Surg. 18(7), 814-818 (2008).
82. Neto NI, Godoy EP, Campos JM et al. Superior mesenteric artery syndrome after laparoscopic sleeve gastrectomy. Obes. Surg 17, 825-827 (2007).
83. Givon-Madhala O, Spector R, Wasserberg N et al. Technical aspects of laparoscopic sleeve gastrectomy in 25 morbidly obese patients. Obes. Surg. 17, 722-727 (2007).
84. Baltasar A, Bou R, Bengochea M et al. Use of a Roux limb to correct esophagogastric junction fstulas after sleeve gastrectomy. Obes. Surg. 17, 1408-1410 (2007).
85. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes. Surg. 14, 492-497 (2004).
86. Bernante P, Foletto M, Busetto L et al. Feasibility of laparoscopic sleeve gastrectomy as a revision procedure for prior laparoscopic gastric banding. Obes. Surg. 16, 1327-1330 (2006).
87. Ou Yang O, Loi K, Liew V, Talbot M, Jorgensen J. Staged laparoscopic sleeve gastrectomy followed by Roux-en-Y gastric bypass for morbidly obese patients: a risk reduction strategy. Obes. Surg. 18, 1575-1580 (2008).
88. 2). Surg. Today 38, 399-403 (2008).
89. Takata MC, Campos GM, Ciovica R et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg. Obes. Relat. Dis. 4, 159-164; discussion 64-65 (2008).
90. Tagaya N, Kasama K, Kikkawa R et al. Experience with laparoscopic sleeve gastrectomy for morbid versus super morbid obesity. Obes. Surg. 19(10), 1371-1376 (2008).
91. Nocca D, Krawczykowsky D, Bomans B et al. A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes. Surg. 18, 560-565 (2008).
92. Rubin M, Yehoshua RT, Stein M et al. Laparoscopic sleeve gastrectomy with minimal morbidity early results in 120 morbidly obese patients. Obes. Surg. 18(12), 1567-1570 (2008).
93. Skrekas G, Lapatsanis D, Stafyla V, Papalambros A. One year after laparoscopic 'tight' sleeve gastrectomy: technique and outcome. Obes. Surg. 18, 810-813 (2008).
94. Mui WL, Ng EK, Tsung BY, Lam CC, Yung MY. Laparoscopic sleeve gastrectomy in ethnic obese chinese. Obes. Surg. 18(12), 1571-1574 (2008).
95. Hakeam HA, O'Regan PJ, Salem AM, Bamehriz FY, Jomaa LF. Inhibition of C-reactive protein in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes. Surg. 19(4), 456-460 (2008).
96. Quesada BM, Roff HE, Kohan G, Salvador Oria A, Chiappetta Porras LT. Laparoscopic sleeve gastrectomy as an alternative to gastric bypass in patients with multiple intraabdominal adhesions. Obes. Surg. 18, 566-568 (2008).
97. Fuks D, Verhaeghe P, Brehant O et al. Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surgery 145, 106-113 (2009).
98. Uglioni B, Wolnerhanssen B, Peters T, Christoffel-Courtin C, Kern B, Peterli R. Midterm results of primary vs. secondary laparoscopic sleeve gastrectomy (LSG) as an isolated operation. Obes. Surg. 19(4), 401-406 (2009).